C
Clinica Amo | Casarao Rio Vermelho - Instituto Etica
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Nivolumab
-ipilimumab
SAR441344
Frexalimab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 2 total trials
The purpose of each study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to a daily oral do...
Enrolling
Multiple Sclerosis
Drug: Activated charcoal
Drug: Cholestyramine
A total of 112 patients with locally advanced cervical cancer will be randomized 1:1 to standard therapy with cisplatin-based chemoradiation or nivol...
Enrolling
Uterine Cervical Neoplasms
Radiation: Chemoradiation
Drug: Nivolumab 40 mg in 4 ml Injection
Trial sponsors
H
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems